Therapeutic antibodies are evolving to address challenges in specificity, resistance, and delivery. Through structural insight and modular engineering, emerging formats can engage multiple targets, deliver potent payloads, or neutralize complex toxins — broadening therapeutic scope while improving precision and mechanistic control.
Download this eBook to learn:
- How bispecific antibodies are engineered to improve immune synapse formation and overcome resistance
- Key components and cytotoxic strategies used in antibody–guided conjugates
- Why engineered single-domain antibodies offer new possibilities for treating neglected diseases
